NIGERIA – The Board of Directors of Neimeth Pharmaceuticals, a company that is into manufacturing and marketing of pharmaceuticals and animal health products, has revealed plans to raise N5 billion (US$13.11m) in additional equity upon approval by shareholders of the company, reports Nairametrics. The fund will help the company’s management to execute key strategies that will reposition the company as a leader in the healthcare industry, with the hope to deliver better returns on investment to shareholders. The additional equity financing will also increase Neimeth’s outstanding shares, which will dilute…
Read MoreNeimeth Pharmaceuticals to raise US$13m additional equity for execution of key strategies
